Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Florence Lebon"'
Autor:
Bingfa Sun, Dan Feng, Matthew Ling-Hon Chu, Inbar Fish, Silvia Lovera, Zara A. Sands, Sebastian Kelm, Anne Valade, Martyn Wood, Tom Ceska, Tong Sun Kobilka, Florence Lebon, Brian K. Kobilka
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-9 (2021)
Recently, a class of non-catechol Dopamine D1 receptor (D1R) selective agonists with novel scaffold and improved pharmacological properties were reported. Here, authors report the crystal structure of D1R in complex with stimulatory G protein (Gs) an
Externí odkaz:
https://doaj.org/article/2dbb4259799647b08364c62567b2949b
Autor:
Michael Kriegbaum Skjødt, Joeri Nicolaes, Christopher Dyer Smith, Jonas Banefelt, Florence Lebon, Cesar Libanati, Kim Rose Olsen, Cyrus Cooper, Bo Abrahamsen
Publikováno v:
Bone Reports, Vol 13, Iss , Pp 100555- (2020)
Externí odkaz:
https://doaj.org/article/ae48fe2a848c49a396dccedb0e47d6a9
Publikováno v:
PLoS ONE, Vol 10, Iss 2, p e0116589 (2015)
The putative Major Facilitator Superfamily (MFS) transporter, SV2A, is the target for levetiracetam (LEV), which is a successful anti-epileptic drug. Furthermore, SV2A knock out mice display a severe seizure phenotype and die after a few weeks. Despi
Externí odkaz:
https://doaj.org/article/ae42f1295e90453ba5296467551df3bc
Autor:
Sebastian Kelm, Bingfa Sun, Inbar Fish, Matthew Ling-Hon Chu, Florence Lebon, Zara A. Sands, Martyn Wood, Dan Feng, Tong Sun Kobilka, Brian K. Kobilka, Silvia Lovera, Tom Ceska, Anne Valade
Publikováno v:
Nature Communications
Nature Communications, Vol 12, Iss 1, Pp 1-9 (2021)
Nature Communications, Vol 12, Iss 1, Pp 1-9 (2021)
Dopamine D1 receptor (D1R) is an important drug target implicated in many psychiatric and neurological disorders. Selective agonism of D1R are sought to be the therapeutic strategy for these disorders. Most selective D1R agonists share a dopamine-lik
Autor:
Zara A. Sands, Florence Lebon, Matthew Ling-Hon Chu, Tong Sun Kobilka, Joël Mercier, Priti Bachhawat, Tom Ceska, Brian K. Kobilka, Martyn Wood, Bingfa Sun
Publikováno v:
Proceedings of the National Academy of Sciences. 114:2066-2071
The adenosine A2A receptor (A2AR) has long been implicated in cardiovascular disorders. As more selective A2AR ligands are being identified, its roles in other disorders, such as Parkinson’s disease, are starting to emerge, and A2AR antagonists are
Autor:
Joeri Nicolaes, Jonas Banefelt, Bo Abrahamsen, Christopher D. Smith, Florence Lebon, Cesar Libanati, Michael K Skjødt, Kim Rose Olsen, Cyrus Cooper
Publikováno v:
Bone Reports, Vol 13, Iss, Pp 100555-(2020)
Skjødt, M K, Nicolaes, J, Smith, C D, Banefelt, J, Lebon, F, Libanati, C, Olsen, K R, Cooper, C & Abrahamsen, B 2020, ' The potential for opportunistic identification of vertebral fractures in patients undergoing a CT scan as part of daily clinical practice : Descriptive study using registry data ', Bone Reports, vol. 13, no. Suppl., P257 . https://doi.org/10.1016/j.bonr.2020.100555
Skjødt, M K, Nicolaes, J, Smith, C D, Banefelt, J, Lebon, F, Libanati, C, Olsen, K R, Cooper, C & Abrahamsen, B 2020, ' The potential for opportunistic identification of vertebral fractures in patients undergoing a CT scan as part of daily clinical practice : Descriptive study using registry data ', Bone Reports, vol. 13, no. Suppl., P257 . https://doi.org/10.1016/j.bonr.2020.100555
Autor:
Bingfa, Sun, Priti, Bachhawat, Matthew Ling-Hon, Chu, Martyn, Wood, Tom, Ceska, Zara A, Sands, Joel, Mercier, Florence, Lebon, Tong Sun, Kobilka, Brian K, Kobilka
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America. 114(8)
The A2AR is a G protein-coupled receptor (GPCR) that plays important roles in cardiovascular physiology and immune function. The A2AR is also a target for the treatment of Parkinson’s disease, where A2AR antagonists have been shown to enhance signa
Autor:
Ledecq Marie, Stéphane Meunier, Benoit Mathieu, Laurent Provins, Christian Wolff, Sébastien Lengelé, Alain Wagner, Anne Frycia, Florence Lebon, Nathalie Bosman, Cecile Pegurier, Kashinath Dhurke, Ananda Kumar Kanduluru
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 22:3978-3982
A multi-disciplinary approach was used to identify the first pharmacophore model for KCC2 blockers: several physico-chemical studies such as XRD and NMR were combined to molecular modelling techniques, SAR analysis and synthesis of constrained analog
Autor:
Iwan J. P. de Esch, Yves Lamberty, Patrice Talaga, Valérie Verbois, Rob Leurs, Frédéric Denonne, Florence Lebon, Alain Vanbellinghen, Bernard Christophe, Michel Gillard, Christel Delaunoy, Sylvain Celanire, Edith Gelens, Erwin Snip, Henk Timmerman, Donald Dassesse, Nathalie Van houtvin, Laurent Provins, Benedicte Lallemand, Véronique Durieu, Philippe Collart, Jean-Marie Nicolas, Maikel Wijtmans, Luc Quere
Publikováno v:
ChemMedChem, 4(7), 1063-8. John Wiley and Sons Ltd
Celanire, S, Wijtmans, M, Christophe, B, Collart, P, de Esch, I J P, Dassesse, D, Delaunoy, C, Denonne, F, Durieu, V, Gelens, E, Gillard, M, Lallemand, B, Lamberty, Y, Lebon, F, Nicolas, J M, Quere, L, Snip, E, Vanbellinghen, A, Van Houtvin, N, Verbois, V, Timmerman, H, Talaga, P, Leurs, R & Provins, L 2009, ' Discovery of a new class of non-imidazole oxazoline-based histamine H(3) receptor (H(3)R) inverse agonists ', ChemMedChem, vol. 4, no. 7, pp. 1063-8 . https://doi.org/10.1002/cmdc.200900055
Celanire, S, Wijtmans, M, Christophe, B, Collart, P, de Esch, I J P, Dassesse, D, Delaunoy, C, Denonne, F, Durieu, V, Gelens, E, Gillard, M, Lallemand, B, Lamberty, Y, Lebon, F, Nicolas, J M, Quere, L, Snip, E, Vanbellinghen, A, Van Houtvin, N, Verbois, V, Timmerman, H, Talaga, P, Leurs, R & Provins, L 2009, ' Discovery of a new class of non-imidazole oxazoline-based histamine H(3) receptor (H(3)R) inverse agonists ', ChemMedChem, vol. 4, no. 7, pp. 1063-8 . https://doi.org/10.1002/cmdc.200900055
H(3)R inverse agonists based on an aminopropoxy-phenyloxazoline framework constitute highly valuable druglike lead compounds that display efficacy in a mouse model of recognition memory.
Autor:
Bernard Christophe, Philippe P. Collart, Bastiaan J. Venhuis, Maikel Wijtmans, Saskia Hulscher, Benedicte Lallemand, Edith Gelens, Patrice Talaga, Iwan J. P. de Esch, Michel Gillard, Erwin Snip, Sylvain Celanire, Henk Timmerman, Rob Leurs, Henk van der Goot, Florence Lebon, Remko A. Bakker
Publikováno v:
Wijtmans, M, Celanire, S, Snip, E, Gillard, M R, Gelens, E, Collart, P P, Venhuis, B J, Christophe, B, Hulscher, ST, van der Goot, H, Lebon, F, Timmerman, H, Bakker, R A, Leurs, R, Lallemand, B I, Talaga, P & de Esch, I J P 2008, ' 4-benzyl-1H-imidazoles with oxazoline termini as histamine H3 receptor agonists ', Journal of Medicinal Chemistry, vol. 51, no. 10, pp. 2944-53 . https://doi.org/10.1021/jm7014149
Journal of Medicinal Chemistry, 51(10), 2944-53. American Chemical Society
Journal of Medicinal Chemistry, 51(10), 2944-53. American Chemical Society
Research on the therapeutic applications of the histamine H3 receptor (H3R) has traditionally focused on antagonists/inverse agonists. In contrast, H3R agonists have received less attention despite their potential use in several disease areas. The lo